Patents by Inventor Aihua Song

Aihua Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220289857
    Abstract: An antibody or antigen binding fragment thereof that binds to a Fn14, wherein the antibody or antigen binding fragment thereof is an antagonist and non-agonist of Fn14.
    Type: Application
    Filed: December 19, 2019
    Publication date: September 15, 2022
    Applicant: KYOWA KIRIN CO., LTD.
    Inventors: Aihua SONG, Andrew John MCKNIGHT, Rachel Soloff NUGENT, John Lorca LAUDENSLAGER, Giuseppe DESTITO, Sarah Sunrise BUBECK, Shinya OGAWA, Yuji YAMAZAKI, David MILLS, Aruna BITRA, Dirk Michael ZAJONC
  • Patent number: 8420784
    Abstract: The invention relates to IL-1O Receptor alpha (IL-1OR?) antibodies and subsequences thereof, human and humanized IL-10 Receptor alpha (IL-IOR?) antibodies and subsequences thereof, isolated and purified IL-10 Receptor alpha (IL-1OR?) antibodies and subsequences thereof, compositions including IL-10 Receptor alpha (IL-1OR?) antibodies and subsequences thereof, and methods that employ IL-10 Receptor alpha (IL-1OR?) antibodies and subsequences thereof. The invention includes among other things, methods of treating a pathogen infection, pathogen reactivation, and methods of vaccinating or immunizing against a pathogen infection, which include, for example, administering an IL-10 Receptor alpha (IL-1OR?) antibody or subsequence, to treat a pathogen infection, pathogen reactivation or for vaccination or immunization.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: April 16, 2013
    Assignee: Kyowa Hakko Kirin Co., Ltd.
    Inventors: Shinichiro Kato, Rachel Soloff Nugent, Tomoyuki Tahara, Paul Rogers, Aihua Song
  • Publication number: 20110144312
    Abstract: The invention relates to IL-1O Receptor alpha (IL-1OR?) antibodies and subsequences thereof, human and humanized IL-10 Receptor alpha (IL-IOR?) antibodies and subsequences thereof, isolated and purified IL-10 Receptor alpha (IL-1OR?) antibodies and subsequences thereof, compositions including IL-10 Receptor alpha (IL-1OR?) antibodies and subsequences thereof, and methods that employ IL-10 Receptor alpha (IL-1OR?) antibodies and subsequences thereof. The invention includes among other things, methods of treating a pathogen infection, pathogen reactivation, and methods of vaccinating or immunizing against a pathogen infection, which include, for example, administering an IL-10 Receptor alpha (IL-1OR?) antibody or subsequence, to treat a pathogen infection, pathogen reactivation or for vaccination or immunization.
    Type: Application
    Filed: May 27, 2009
    Publication date: June 16, 2011
    Applicant: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Shinichiro Kato, Rachel Soloff Nugent, Tomoyuki Tahara, Paul Rogers, Aihua Song
  • Patent number: 5252218
    Abstract: A method for processing a flowable nonaqueous, high viscosity dispersion which includes a product, where the product is a particulate material having a particle size between about 1.0 microns to about 200 microns, is disclosed. The flowable dispersion has a viscosity from about 10 cps to about 500 cps at 140.degree. F. The method comprises cross flow filtering the dispersion through a porous nonmetallic inorganic filter having a pore size from about 0.5 to about 10 microns. The cross flow rate is in the range of from about 3.0 to about 9.0 feet/second (1 to 3 ml/sec) at least about 120.degree. F. and preferably there is at least one backflush at a rate of about 2 to about 5 seconds for every 3 to about 5 minutes of cross flow filtration.
    Type: Grant
    Filed: June 2, 1992
    Date of Patent: October 12, 1993
    Assignee: Cargill, Incorporated
    Inventors: Harapanahalli S. Muraldihara, Aihua Song